Received: 25.11.2024 Accepted: 09.12.2024 Published online: 30.12.2024
DOI: 10.26212/2227-1937.2025.83.21.004
УДК: 616.36-002+615.38
PECULIARITIES OF THE COURSE HEPATITIS B AND C INFECTIONS IN HEMODIALYSIS PATIENTS: A LITERATURE REVIEW
Arina Yespotayeva1,2, ORCID: https://orcid.org/0000-0003-2582-1211
Kairat Kabulbayev2, https://orcid.org/: 0000-0002-5977-1569
Almagul Kurmanova1, https://orcid.org/: 0000-0002-1859-3903
Abduzhappar Gaipov3, https://orcid.org/: 0000-0002-9844-8772
Alexander V. Nersesov2, https://orcid.org/0000-0002-8601-3966
Abay Shepetov2, https://orcid.org/0000-0002-2201-5946
Gulnar Chingayeva2, https://orcid.org/0000-0001-6267-5351
Nagima Mustapayeva2
, https://orcid.org/0000-0001-5963-7645
Gainutdin Aisulu2, https://orcid.org/0000-0002-5629-3848
1Al-Farabi Kazakh National University, Almaty, Kazakhstan
2S.D AsfendiyarovKazakh National Medical University, Almaty, Kazakhstan
3Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
Resume
Background. Hepatitis B (HBV) and Hepatitis C (HCV) present significant challenges for hemodialysis patients due to
impaired immunity and frequent blood exposures. Advancements in antiviral therapies, infection control measures, and
vaccination are critical for reducing their burden.
Purpose of the review. To evaluate the epidemiology, management, and prevention of HBV and HCV in hemodialysis
patients. The review synthesized current research on transmission, infection control, antiviral therapies, and vaccination
strategies, emphasizing their role in improving patient outcomes.
Materials and methods. A systematic review of PubMed, Google Scholar, and Cochrane Library (2000–2022) using
keywords like “Hepatitis B,” “Hepatitis C,” “Hemodialysis,” “Infection Control,” and “Vaccination.”
Conclusions: HBV and HCV remain critical concerns in hemodialysis settings. Advances in therapy, combined with
preventive measures, are essential for better patient outcomes and infection control.
Keywords: Hepatitis B, Hepatitis C, Hemodialysis, Infection Control, Antiviral Therapy, Vaccination, Epidemiology.
